Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPSIPB for Postoperative Analgesia in Arthroscopic Shoulder Surgery
NCT06866054Recruiting
- Sponsor
- Kahramanmaraş Sütçü İmam Üniversitesi
- Start
- Apr 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Kahramanmaraş Sütçü İmam Üniversitesi. Primary endpoint: Opioid consumption (Fentanyl PCA) at 24 hours. Started Apr 2025; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06866054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06866054.